Detalhe da pesquisa
1.
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Nat Immunol
; 23(9): 1379-1392, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002648
2.
Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
J Immunol
; 186(9): 5142-50, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21441457
3.
Immunomodulatory properties of CNF1 toxin from E. coli: implications for colorectal carcinogenesis.
Am J Cancer Res
; 12(2): 651-660, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35261793
4.
Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19.
Cytokine Growth Factor Rev
; 63: 23-33, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34955389
5.
Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer Therapies.
Cancers (Basel)
; 13(18)2021 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572726
6.
Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models.
Cells
; 10(4)2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33917958
7.
Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
Trials
; 22(1): 584, 2021 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34479601
8.
Type I IFN regulate DC turnover in vivo.
Eur J Immunol
; 39(7): 1807-18, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19544312
9.
Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy.
Front Immunol
; 11: 582744, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33193392
10.
The role of exosomes in colorectal cancer disease progression and response to therapy.
Cytokine Growth Factor Rev
; 51: 84-91, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31955973
11.
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?
Cytokine Growth Factor Rev
; 54: 43-50, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665127
12.
Enzyme-linked immunospot assay to monitor antigen-specific cellular immune responses in mouse tumor models.
Methods Enzymol
; 632: 457-477, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32000910
13.
Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade.
Cells
; 9(4)2020 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32290265
14.
A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities.
J Cell Mol Med
; 13(8B): 2131-2147, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19604317
15.
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.
Int J Cancer
; 124(1): 130-9, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18839429
16.
Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
Clin Cancer Res
; 13(2 Pt 1): 644-53, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17255288
17.
MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts.
Trends Mol Med
; 12(10): 465-72, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16962375
18.
IFN-alpha and novel strategies of combination therapy for cancer.
Ann N Y Acad Sci
; 1112: 256-68, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17567945
19.
The added value of type I interferons to cytotoxic treatments of cancer.
Cytokine Growth Factor Rev
; 36: 89-97, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28693974
20.
Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.
J Invest Dermatol
; 137(1): 159-169, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27623509